• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anaplastic Large Cell Lymphoma

Anaplastic Large Cell Lymphoma - 61 Studies Found

Active, not recruiting : Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma
:
  • Relapsed or Refractory Hodgkin Lymphoma
  • Relapsed or Refractory Anaplas
    : 2011-12-12
    : Drug: Brentuximab vedotin Brentuximab vedotin IV infusion
Withdrawn : Denileukine Diftitox for Relapsed ALCL
: Anaplastic Large-Cell Lymphoma
: 2008-12-03
:
  • Drug: Denileukin Diftitox Deni

Completed : 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma
:
  • Anaplastic Large Cell Lymphoma
  • Recurrent Adult Hodgkin Lymphoma
    : 2005-07-08
    : Drug: tanespimycin Other Name: 17-AAG
Completed : Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL
: ALK+ Anaplastic Large Cell Lymphoma
: 2015-05-18
:
  • Drug: Brentuximab vedotin Bren

Recruiting : Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
:
  • Recurrent Childhood Anaplastic Large Cell Lymphoma
  • Recurrent Ne
    : 2012-05-24
    :
    • Drug: crizotinib Given orally

Suspended : Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
:
  • Anaplastic Large Cell Lymphoma, ALK-Positive
  • CD30-Positive Neop
    : 2013-11-04
    :
    • Drug: Brentuximab Vedotin Give

Completed : Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
: Lymphoma
: 2011-06-02
:
  • Genetic: microarray analysis
  • Genetic: prot

Completed : Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
: Lymphoma
: 2003-05-06
:
  • Drug: doxorubicin hydrochloride

Active, not recruiting : Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
: Lymphoma
: 2006-04-19
:
  • Biological: anti-thymocyte globulin
  • Drug:

Active, not recruiting : Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma
: Lymphoma
: 2000-11-06
:
  • Drug: cyclophosphamide
  • Drug: cytarabine

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.